Who Owns NeuroOne Medical Technologies Stock?
NASDAQ: NMTCHealthcareMedical DevicesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 1.06 -1.85%
Ownership breakdown
- Held by institutions
- 22.45%
- Held by insiders
- 25.44%
- Institutional holders
- 27
- Institutions 22.4%
- Insiders 25.4%
- Public and other 52.1%
Who owns NeuroOne Medical Technologies stock?
Institutional investors own about 22.4% of NeuroOne Medical Technologies's shares, spread across 27 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 25.44% of NMTC.
The largest institutional holders are Bleichroeder LP (7.32%), Vanguard Capital Management LLC (3.87%) and Bard Associates Inc. (3.35%). Together, the top 10 institutions control 21.3% of shares outstanding. In their latest filings, 2 of the top 10 institutions increased their NMTC positions and 5 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of NMTC
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Bleichroeder LP | 666.67K | 7.32% | 0.0% |
| Vanguard Capital Management LLC | 352.77K | 3.87% | +51.5% |
| Bard Associates Inc. | 305.43K | 3.35% | -0.4% |
| Perkins Capital Management, Inc. | 244.66K | 2.69% | -0.3% |
| Geode Capital Management, LLC | 93.56K | 1.03% | -8.8% |
| Sio Capital Management, LLC | 82.77K | 0.91% | 0.0% |
| Renaissance Technologies, LLC | 70.86K | 0.78% | -35.1% |
| Vanguard Fiduciary Trust Co | 49.02K | 0.54% | +0.7% |
| Essex Investment Management Co LLC | 43.58K | 0.48% | -0.2% |
| Cambridge Investment Research Advisors Inc. | 28.50K | 0.31% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of NMTC
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 254.94K | 2.80% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 90.12K | 0.99% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 45.05K | 0.49% |
| iShares Trust-iShares Micro-Cap ETF | 23.49K | 0.26% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 13.91K | 0.15% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 11.88K | 0.13% |
| VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fund | 7.72K | 0.08% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 4.66K | 0.05% |
| EQ Advisors Trust-1290 VT Micro Cap Portfolio | 1.48K | 0.02% |
Frequently asked questions
Who is the largest shareholder of NeuroOne Medical Technologies?
Bleichroeder LP is the largest institutional shareholder of NMTC, owning 7.32% of shares outstanding (666.67K shares) as of its latest 13F filing.
What percentage of NeuroOne Medical Technologies is owned by institutions?
Institutions own about 22.4% of NMTC shares and 30.1% of the public float.
How much of NeuroOne Medical Technologies do insiders own?
Insiders, such as officers and directors, own about 25.44% of NMTC shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.